Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FSUFN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,634
Award facts
- Contract value 100% obligated
- $2,633.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,633.54 delivery order to AmerisourceBergen Drug Corp for ZEPBOUND 10 mg/0.5 ml pens on November 7, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. ZEPBOUND is a GLP-1 receptor agonist used in diabetes and weight management treatment, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries supporting federal medical procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating proven capability to fulfill federal medical supply requirements across diverse therapeutic domains and transaction scales.
Quick answers
Who was awarded contract SPE2DB26FSUFN?
SPE2DB26FSUFN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FSUFN worth?
The government has obligated $2,634 on SPE2DB26FSUFN.
Is contract SPE2DB26FSUFN an order under another contract?
Yes. SPE2DB26FSUFN is a delivery order under SPE2DB25D7067, an indefinite delivery contract.
Was contract SPE2DB26FSUFN competed?
The extent of competition for SPE2DB26FSUFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award